{"id":"W2294247703","doi":"10.1182/blood.v124.21.1859.1859","title":"Safety and Efficacy of Ruxolitinib in Patients with Low Platelets Enrolled in a Phase 3b Expanded-Access Study in Myelofibrosis (MF)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; St. Paul's Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Tolerability; Internal medicine; Adverse effect; Clinical trial; Phases of clinical research; Clinical endpoint; Discontinuation; Placebo; Surgery; Bone marrow; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002164612,0.0006296166,0.001124074,0.0002764482,0.0003861497,0.000807454,0.0003253598,0.0008522454,0.00202428],"category_scores_gemma":[0.001469071,0.000261594,0.0008943643,0.0002326254,0.0002830426,0.0006594838,0.0003548617,0.001481683,0.0004819478],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003788136,"about_ca_system_score_gemma":0.0005994393,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002866646,"about_ca_topic_score_gemma":0.000531627,"domain_scores_codex":[0.9993935,0.0003286524,0.00003985492,0.00008456444,0.00005862649,0.00009480727],"domain_scores_gemma":[0.9992078,0.0001493927,0.0001950243,0.0000682411,0.00006048011,0.0003191353],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7668942,0.02498994,0.1090111,0.0003719872,0.001478115,0.0007239225,0.0003380209,0.001085425,0.02099358,0.0001500323,0.003177419,0.0707863],"study_design_scores_gemma":[0.3054968,0.4098649,0.270211,0.00007962466,0.001423136,0.001171883,0.0001275196,0.002419478,0.004929371,0.0002658936,0.003950882,0.00005939433],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975145,0.0005394036,0.0002042603,0.0001237371,0.00001910501,0.0005325627,0.0004468991,0.00002334574,0.0005961667],"genre_scores_gemma":[0.9973852,0.0001447253,0.0003034384,0.0002411595,0.00005043321,0.0005402009,0.0009181601,0.000005140067,0.0004116129],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002164612,"threshold_uncertainty_score":0.01144773,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01035313255774024,"score_gpt":0.2835972368085958,"score_spread":0.2732441042508556,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}